JPMorgan Cuts Billiontoone Price Target Amid Ongoing Growth Concerns

JPMorgan Chase & Co. has cut its price target for Billiontoone (NASDAQ:BLLN) from $145 to $130, according to a research note issued by the firm on Thursday.

This move indicates a potential upside of 41.84% from the company's current price. JPMorgan Chase & Co.'s analysts currently have an 'overweight' rating on Billiontoone stock.

Several other investment firms, including BTIG Research and Guggenheim, have also made adjustments to their estimates for Billiontoone. BTIG Research cut its price target from $142 to $130, while maintaining a 'buy' rating on the stock. Guggenheim initiated coverage with a 'buy' rating and a $125 price target.

Billiontoone's current market capitalization stands at $4.21 billion, with a price-to-earnings ratio of 166.64. The company's revenue for the second quarter was $109.45 million, meeting analysts' estimates. Billiontoone has reported continued demand for its molecular diagnostics products.